Literature DB >> 25198520

Predictive value of the parent-completed ASQ for school difficulties in preterm-born children <35 weeks' GA at five years of age.

Marie Halbwachs1, Jean-Baptiste Muller, Sylvie Nguyen The Tich, Geraldine Gascoin, Anne Chauty-Frondas, Bernard Branger, Valérie Rouger, Jean-Christophe Roze, Cyril Flamant.   

Abstract

BACKGROUND: Preterm infants are at greater risk of developmental impairment and require close follow-up for early and optimal care.
OBJECTIVES: The objective of the present study was to determine from which age the parental Ages and Stages Questionnaire (ASQ) allows detection of school difficulties in preterm children <35 weeks' gestational age.
METHODS: Preterm children from the regional Loire Infant Follow-up Team network were evaluated with the Global School Adaptation (GSA) assessment tool at 5 years of age and at least one parental-completed ASQ at 18, 24, or 36 months. Children belonging to the first decile of the GSA score (<38) were considered to have severe school difficulties. Using overall ASQ scores as continuous variables, receiver operating characteristic (ROC) curves were generated at every age in order to identify preterm children with severe school difficulties.
RESULTS: GSA scores were obtained in 1,775 infants at 5 years of age, and at least one ASQ score at 18, 24, or 36 months was completed. Upon ROC analysis, we observed that the 18-, 24-, and 36-month ASQ scores produced respective area under the ROC curve values of 0.66 (0.64-0.69), 0.72 (0.70-0.75), and 0.77 (0.75-0.80) for predicting a GSA score in the first decile. An ASQ cutoff value of 255 at 36 months showed optimal discriminatory power for identifying significant school difficulties at 5 years of age.
CONCLUSIONS: The 36-month ASQ is a simple and cost-effective tool that can be employed to help predict future severe school difficulties at 5 years of age in preterm-born children.

Entities:  

Mesh:

Year:  2014        PMID: 25198520     DOI: 10.1159/000363216

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  6 in total

1.  Stability of developmental status and risk of impairment at 24 and 36 months in late preterm infants.

Authors:  Hooman Mirzakhani; Rachel S Kelly; Aishwarya P Yadama; Su H Chu; Jessica A Lasky-Su; Augusto A Litonjua; Scott T Weiss
Journal:  Infant Behav Dev       Date:  2020-06-26

2.  Breast milk protein content at week 3 after birth and neurodevelopmental outcome in preterm infants fed fortified breast milk.

Authors:  Clair-Yves Boquien; Helene Billard; Laure Simon; Cecile Boscher; Arnaud Legrand; Evelyne Joram; Thomas Moyon; Marie-Cecile Alexandre-Gouabau; Dominique Darmaun; Jean-Christophe Rozé
Journal:  Eur J Nutr       Date:  2021-04-30       Impact factor: 5.614

3.  Prenatal triptan exposure and parent-reported early childhood neurodevelopmental outcomes: an application of propensity score calibration to adjust for unmeasured confounding by migraine severity.

Authors:  Mollie E Wood; Jean A Frazier; Hedvig M E Nordeng; Kate L Lapane
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-11-11       Impact factor: 2.890

4.  Predictive Validity of Developmental Screening Questionnaires for Identifying Children With Later Cognitive or Educational Difficulties: A Systematic Review.

Authors:  Luisa Schonhaut; Andres Maturana; Olenkha Cepeda; Pamela Serón
Journal:  Front Pediatr       Date:  2021-11-24       Impact factor: 3.418

5.  Longitudinal changes in neurodevelopmental outcomes between 18 and 36 months in children with prenatal triptan exposure: findings from the Norwegian Mother and Child Cohort Study.

Authors:  Mollie E Wood; Jean A Frazier; Hedvig M E Nordeng; Kate L Lapane
Journal:  BMJ Open       Date:  2016-09-13       Impact factor: 2.692

6.  Diet quality over time is associated with better development in rural Nepali children.

Authors:  Laurie C Miller; Sumanta Neupane; Neena Joshi; Merina Shrestha; Shailes Neupane; Mahendra Lohani; Andrew L Thorne-Lyman
Journal:  Matern Child Nutr       Date:  2020-02-11       Impact factor: 3.092

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.